CMPX Compass Therapeutics, Inc.

Fundamentals / CIK 0001738021 / USD

Compass Therapeutics, Inc. reported $0 in revenue and a net loss of $86.36M for the fiscal year ended December 31, 2025 (down 100.0% year over year).

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open CMPX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

9 fiscal years (2019 to 2025), reported in USD.

$9.52M$4.76M$0-$76.91MFY 2019 Net Income: -$36K2019FY 2019 Net Income: -$34.74M2019FY 2020 Net Income: -$37K2020FY 2020 Net Income: -$29.50M2020FY 2021 Net Income: -$82.18M2021FY 2022 Net Income: -$39.23M2022FY 2023 Revenue: $0FY 2023 Net Income: -$42.49M2023FY 2024 Revenue: $850KFY 2024 Net Income: -$49.38M2024FY 2025 Revenue: $0FY 2025 Net Income: -$66.49M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Mar 31 Dec 31 Mar 31
Revenue $0 $850K $0 -- -- -- -- -- --
Research & Development $55.97M $42.34M $38.12M $30.00M $20.34M $14.90M -- $22.45M --
Total Operating Expenses $72.84M $57.48M $50.36M $41.66M $81.88M $27.81M -- $34.05M --
Operating Income -$72.84M -$56.62M -$50.36M -$41.66M -$81.88M -$27.81M -$32K -$34.05M -$33K
EBITDA -$72.56M -$56.04M -$49.66M -$40.87M -$81.28M -$25.41M -- -$31.95M --
Interest Income $6.40M $7.30M $7.90M $2.36M $29K $88K -- $743K --
Interest Expense -- -- -- $0 $370K $908K $5.4K $1.23M $3.3K
Income Before Tax -- -- -$42.49M -$39.23M -$82.18M -$29.47M -- -$34.65M --
Income Tax Expense $0 $0 $0 $0 $0 $32K -- $91K --
Net Income -$66.49M -$49.38M -$42.49M -$39.23M -$82.18M -$29.50M -$37K -$34.74M -$36K
Basic EPS -$0.42 -$0.36 -$0.33 -$0.37 -$1.31 -$0.96 -$0.01 -$5.19 -$0.01
Diluted EPS -- -- -- -- -$1.31 -$0.96 -$0.01 -$5.19 -$0.01
Basic Shares Outstanding 157.7M 137.4M 127.0M 105.2M 62.9M 30.8M 5.0M 6.7M 5.0M
Diluted Shares Outstanding -- 137.4M -- -- 62.9M 30.8M 5.0M 6.7M 5.0M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue -- -- -- -- $0 $0 -- --
Research & Development $22.04M $19.58M $13.39M $13.67M $12.83M $16.41M $13.05M $13.04M
Total Operating Expenses $28.80M $26.98M $20.30M $17.99M $15.82M $21.07M $17.97M $16.57M
Operating Income -$28.80M -$26.98M -$20.30M -$17.99M -$15.82M -$21.07M -$17.97M -$16.57M
EBITDA -$28.77M -$26.96M -$20.28M -$17.97M -$15.80M -$20.97M -$17.83M -$16.43M
Interest Income -- -- -- -- -- $1.20M $1.30M $1.60M
Income Before Tax -- -- -- -- -- -- -$16.63M --
Income Tax Expense -- -- -- -- -- -- $0 --
Net Income -$27.17M -$25.15M -$18.32M -$15.72M -$14.26M -$19.88M -$16.63M -$15.03M
Basic EPS -$0.15 -$0.13 -$0.10 -- -$0.08 -$0.14 -$0.12 --
Basic Shares Outstanding 186.8M 186.8M 186.4M -- 168.8M 138.3M 138.2M --
Diluted Shares Outstanding -- -- -- -- -- -- 138.2M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Mar 31 Dec 31 Mar 31 Mar 31
Cash & Cash Equivalents $30.64M $43.48M $24.23M $34.95M $144.5M $47.08M $3.7K $25.30M $4.9K --
Short-Term Investments $178.3M $83.24M $128.2M $151.7M $0 -- -- -- -- --
Cash & Short-Term Investments $208.9M $126.7M $152.5M $186.6M $144.5M $47.08M $3.7K $25.30M $4.9K --
Total Current Assets $209.8M $132.8M $153.9M $194.8M $147.1M $50.20M $3.7K $26.24M $4.9K $25
Property, Plant & Equipment, Net $102K $353K $898K $1.57M $2.24M $1.13M -- $3.75M -- --
Other Non-Current Assets -- $568K $320K $320K $320K $320K -- $129K -- --
Total Non-Current Assets $9.77M $7.65M $2.99M $4.85M $6.65M $1.71M $0 $4.14M $0 $0
Total Assets $219.6M $140.4M $156.9M $199.6M $153.8M $51.91M $3.7K $30.38M $4.9K $25
Accounts Payable $1.58M $2.25M $4.09M $3.38M $867K $1.06M -- $629K -- --
Short-Term Debt -- -- -- -- $0 $7.47M -- $5.58M -- --
Total Current Liabilities $13.97M $8.87M $7.80M $16.17M $10.63M $10.10M $112K $9.82M $75K $35K
Long-Term Debt -- -- -- -- $0 $1.87M -- $9.29M -- --
Total Non-Current Liabilities $8.83M $6.30M $536K $1.84M $3.05M $1.87M $0 $9.29M $0 $0
Total Liabilities $22.80M $15.17M $8.34M $18.01M $13.68M $11.97M $112K $19.11M $75K $35K
Total Debt (incl. Leases) $9.83M $6.63M $1.73M $2.94M $4.04M $9.33M -- $14.87M -- --
Common Stock $18K $14K $13K $13K $10K $5.0K $500 $1.0K $500 $500
Retained Earnings -$431.2M -$364.7M -$315.3M -$272.8M -$233.6M -$151.4M -$109K -$121.9M -$71K -$35K
Accumulated Other Comp. Income $280K $210K $37K -$302K $0 -- -- -- -- --
Total Stockholders' Equity $196.8M $125.2M $148.5M $181.6M $140.1M $39.95M -$124.8M $11.27M -$95.29M -$35K
Total Equity $196.8M $125.2M $148.5M $181.6M $140.1M $39.95M -$124.8M $11.27M -$95.29M -$35K

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $41.47M $35.45M $55.17M $30.64M $46.21M $22.86M $41.05M $43.48M
Short-Term Investments $121.6M $144.4M $139.5M $178.3M $173.7M $78.09M $71.59M $83.24M
Cash & Short-Term Investments $163.1M $179.9M $194.7M $208.9M $219.9M $100.9M $112.6M $126.7M
Total Current Assets $165.5M $180.9M $195.7M $209.8M $221.1M $106.2M $124.1M $132.8M
Property, Plant & Equipment, Net $402K $324K $169K $102K $119K $131K $102K $353K
Other Non-Current Assets -- -- -- -- -- -- -- $568K
Total Non-Current Assets $9.00M $9.28M $9.48M $9.77M $10.14M $10.50M $7.31M $7.65M
Total Assets $174.5M $190.2M $205.2M $219.6M $231.3M $116.7M $131.5M $140.4M
Accounts Payable $6.32M $2.91M $906K $1.58M $3.10M $2.60M $1.58M $2.25M
Total Current Liabilities $24.37M $16.13M $10.28M $13.97M $12.41M $13.86M $14.90M $8.87M
Total Non-Current Liabilities $7.56M $8.00M $8.42M $8.83M $9.23M $9.63M $6.27M $6.30M
Total Liabilities $31.93M $24.12M $18.70M $22.80M $21.65M $23.49M $21.17M $15.17M
Total Debt (incl. Leases) $9.23M $9.63M $9.79M $9.83M $9.83M $9.90M $6.38M $6.63M
Common Stock $18K $18K $18K $18K $53K $14K $14K $14K
Retained Earnings -$501.8M -$474.6M -$449.5M -$431.2M -$415.5M -$401.2M -$381.3M -$364.7M
Accumulated Other Comp. Income -$566K -$251K -$159K $280K $274K $208K $190K $210K
Total Stockholders' Equity $142.6M $166.0M $186.5M $196.8M $209.6M $93.21M $110.3M $125.2M
Total Equity $142.6M $166.0M $186.5M $196.8M $209.6M $93.21M $110.3M $125.2M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Mar 31 Dec 31 Mar 31
Net Income -$66.49M -$49.38M -$42.49M -$39.23M -$82.18M -$29.50M -$37K -$34.74M -$36K
Depreciation & Amortization $276K $589K $699K $782K $600K $2.40M -- $2.10M --
Stock-Based Compensation $8.37M $8.56M $6.12M $5.33M $4.03M $4.02M -- $915K --
Change in Payables -$664K -$1.84M $708K $2.52M -$194K $432K -- -$1.10M --
Operating Cash Flow -$49.14M -$44.85M -$40.62M -$34.12M -$19.67M -$26.80M -$32K -$31.74M -$33K
Capital Expenditure -$25K -$44K -$30K -$212K -$1.57M -$106K -- -$466K --
Free Cash Flow -$49.17M -$44.90M -$40.65M -$34.34M -$21.23M -$26.91M -- -$32.21M --
Acquisitions, Net -- -- -- $0 -$318K -- -- -- --
Purchases of Investments -$194.6M -$88.16M -$155.4M -$200.1M $0 -- -- -- --
Investing Cash Flow -$93.31M $46.77M $26.96M -$151.2M -$1.77M $38K -- -$466K --
Common Stock Issued $138.0M $18.11M $3.13M $76.24M $128.3M $60.48M -- -- --
Financing Cash Flow $129.6M $17.34M $2.94M $75.76M $118.6M $48.54M $31K -- $38K
Net Change in Cash -$12.84M $19.25M -$10.72M -$109.6M $97.17M $21.77M -$1.1K -$32.21M $4.9K

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$27.17M -$25.15M -$18.32M -$15.72M -$14.26M -$19.88M -$16.63M -$15.03M
Depreciation & Amortization $28K $21K $15K $17K $19K $100K $140K $140K
Stock-Based Compensation $4.01M $4.82M $5.07M $1.82M $1.24M $2.79M $2.51M $2.24M
Change in Payables $3.41M $2.00M -$679K -$1.51M $500K $1.02M -$672K $1.29M
Operating Cash Flow -$16.32M -$14.74M -$17.27M -$13.25M -$10.85M -$11.83M -$13.21M -$9.16M
Capital Expenditure -$106K -$176K -$82K $0 -$7.0K $0 -$18K $0
Free Cash Flow -$16.42M -$14.91M -$17.35M -$13.25M -$10.86M -$11.83M -$13.23M -$9.16M
Purchases of Investments -$5.54M -$40.62M -$44.81M -$27.48M -$109.1M -$33.17M -$24.83M -$9.86M
Investing Cash Flow $22.33M -$4.98M $38.43M -$3.38M -$95.16M -$6.36M $11.59M $15.37M
Common Stock Issued -- -- -- $0 $138.0M $0 $0 $0
Financing Cash Flow $0 $0 $3.37M $1.06M $129.4M $0 -$815K -$94K
Net Change in Cash $6.02M -$19.71M $24.52M -$15.57M $23.36M -$18.19M -$2.44M $6.11M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Mar 31 Dec 31 Mar 31
Operating Margin -- -6661.8% -- -- -- -- -- -- --
Net Profit Margin -- -5808.8% -- -- -- -- -- -- --
Return on Equity (ROE) -33.8% -39.4% -28.6% -21.6% -58.7% -73.9% -- -308.4% --
Return on Assets (ROA) -30.3% -35.2% -27.1% -19.6% -53.4% -56.8% -1000.9% -114.4% -740.6%
Current Ratio 15.02x 14.96x 19.73x 12.05x 13.84x 4.97x 0.03x 2.67x 0.06x
Quick Ratio 14.96x 14.28x 19.54x 11.54x 13.59x 4.66x 0.03x 2.58x 0.06x
Debt to Equity 0.05x 0.05x 0.01x 0.02x 0.03x 0.23x -- 1.32x --
Revenue Growth (YoY) -100.0% -- -- -- -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -60.6% -44.2% -36.6% -33.8% -31.4% -66.5% -50.1% -39.4%
Return on Assets (ROA) -49.5% -38.6% -33.2% -30.3% -28.5% -53.2% -42.0% -35.2%
Current Ratio 6.79x 11.22x 19.04x 15.02x 17.82x 7.66x 8.33x 14.96x
Quick Ratio 6.69x 11.15x 18.94x 14.96x 17.72x 7.28x 7.56x 14.28x
Debt to Equity 0.06x 0.06x 0.05x 0.05x 0.05x 0.11x 0.06x 0.05x
Revenue Growth (YoY) -- -- -- -- -- -100.0% -- --
Source: SEC EDGAR CompanyFacts (CIK 0001738021) · from March 31, 2018 Data through September 30, 2026 · synced Nov 20, 2026, 05:46 UTC · Open in terminal